Hodgkin's lymphoma Posts on Medivizor
Navigation Menu

Hodgkin’s lymphoma Posts on Medivizor

Guest Post: Hodgkin’s Lymphoma and My Stem Cell Transplant Experience

Guest Post: Hodgkin’s Lymphoma and My Stem Cell Transplant Experience

Posted by on Jun 15, 2017 in Blog, Hodgkin's lymphoma | 0 comments

“I am 24 years old.  Last year on January 15th 2016, I was diagnosed with Stage 2A Classical Nodular Sclerosing Hodgkin’s Lymphoma. I had 12 cycles of ABVD chemotherapy over 6 months and went into complete remission on August 8th, 2016. A few weeks before my wedding, on November 4th 2016 I had my first follow up CT scan  which showed enlarged...

Read More

Knowledge is Power: Help For People With Hodgkin’s Lymphoma

Knowledge is Power: Help For People With Hodgkin’s Lymphoma

Posted by on Jun 12, 2017 in Blog, Hodgkin's lymphoma | 1 comment

“Family and friends can be great sources of support but truth be told, no one can ever really know what you are going through other than those who have been there themselves….” ~Rachele Chaar Ghosn For Rachele Chaar Ghosn, a 24-year-old woman with Hodgkin’s Lymphoma, finding others going through treatment for Hodgkins was paramount....

Read More

Carboplatin as a replacement for cisplatin in DHAP chemotherapy for Hodgkin lymphoma

Posted by on Jun 6, 2017 in Hodgkin's lymphoma | 0 comments

In a nutshell The authors investigated the use of carboplatin instead of cisplatin in the DHAP chemotherapy regimen. The authors concluded that carboplatin is less toxic that cisplatin, and may be a good substitute.  Some background Hodgkin lymphoma (HL) is generally considered a curable disease. However, some patients do not respond to first...

Read More

Bone marrow biopsy versus PET/CT scan for staging classical Hodgkin lymphoma

Posted by on May 29, 2017 in Hodgkin's lymphoma | 0 comments

In a nutshell This study examined whether bone marrow biopsies are necessary if PET scans are used to stage classical Hodgkin lymphoma. The study concluded that patients can safely be staged with PET/CT scans without bone marrow biopsy. Some background Hodgkin lymphoma (HL) is widely considered a curable disease. Between 4 and 11% of patients with...

Read More

Long term follow-up study of reduced intensity treatments for early stage Hodgkin lymphoma

Posted by on May 29, 2017 in Hodgkin's lymphoma | 0 comments

In a nutshell This study provided a long-term follow-up of patients diagnosed with early-stage Hodgkin lymphoma. The study concluded that current strategies for reduced intensity treatment of early-stage Hodgkin lymphoma are generally safe and effective.  Some background Hodgkin lymphoma (HL) is generally considered a curable disease....

Read More

Adding rituximab to escalated BEACOPP therapy in Hodgkin Lymphoma patients with a positive PET scan

Posted by on May 15, 2017 in Hodgkin's lymphoma | 0 comments

In a nutshell This study assessed the effectiveness of using escalated BEACOPP plus rituximab chemotherapy in patients with advanced stage Hodgkin Lymphoma. The study concluded that adding rituximab to the standard escalated BEACOPP regimen did not significantly improve time to disease progression. Some background Hodgkin Lymphoma (HL) is...

Read More

The use of donor stem cell transplantation in patients with relapsed Hodgkin lymphoma

Posted by on Apr 14, 2017 in Hodgkin's lymphoma | 0 comments

In a nutshell The authors examined haploidentical (matched donor) stem cell transplantation (haplo-SCT) as a treatment for patients who relapsed after autologous stem cell transplantation. The study concluded that haplo-SCT is a valid treatment for patients with relapsed Hodgkin lymphoma. Some background Most cases of Hodgkin lymphoma (HL) can be...

Read More

Late effects of Hodgkin lymphoma in teenager and young adult survivors

Posted by on Apr 14, 2017 in Hodgkin's lymphoma | 0 comments

In a nutshell This study investigated the amount of late complications that affect teenage and young adult Hodgkin lymphoma survivors. The authors concluded that these patients had higher risks of developing other cancers and getting sick compared to the general population. Some background Hodgkin lymphoma (HL) is the most common cancer among...

Read More

Use of brentuximab vedotin in Hodgin lymphoma patients before allogenic stem cell transplantation

Posted by on Apr 14, 2017 in Hodgkin's lymphoma | 0 comments

In a nutshell This study examined the outcomes for patients who received brentuximab vedotin before allogenic stem cell transplantation. The authors concluded that patients treated with brentuximab vedotin had generally good outcomes. Some background Hodgkin lymphoma (HL) is generally considered a curable disease. However, some patients will not...

Read More

Risk factors for relapse after autologous stem cell transplantation

Posted by on Apr 14, 2017 in Hodgkin's lymphoma | 0 comments

In a nutshell The authors looked at several risk factors that may be associated with relapse after autologous stem cell transplantation (ASCT). The authors found that 5 risk factors were independently associated with relapse after ASCT: stage IV cancer before ASCT; less than 3 months between previous treatment and relapse; performance status of 1 or...

Read More